Articles with "claims data" as a keyword



Information Bias in Electronic Health Records and Administrative Claims Data: A Targeted Review of the Recent Literature.

Sign Up to like & get
recommendations!
Published in 2025 at "Clinical pharmacology and therapeutics"

DOI: 10.1002/cpt.70105

Abstract: Randomized clinical trials represent the primary source of evidence for regulatory and health technology assessment (HTA) decision making; however, the integration of real‐world evidence (RWE) has increased in recent years. Despite its utility, RWE is… read more here.

Keywords: information; claims data; information bias; literature ... See more keywords

Pediatric Drug Adherence and Parental Attention: Evidence From Comprehensive Claims Data.

Sign Up to like & get
recommendations!
Published in 2025 at "Health economics"

DOI: 10.1002/hec.70062

Abstract: ABSTRACT Using comprehensive U.S. drug claims data, we show that adherence to asthma control medication declined during the COVID‐19 pandemic. We find that young children exhibited a 40 percent decrease in adherence by the end… read more here.

Keywords: claims data; adherence; drug; parental attention ... See more keywords
Photo from academic.microsoft.com

Improving measurement of binary covariates in claims data: A simulation study

Sign Up to like & get
recommendations!
Published in 2020 at "Pharmacoepidemiology and Drug Safety"

DOI: 10.1002/pds.4961

Abstract: When investigators have two claims‐based definitions for a binary confounder, it is unclear whether to prefer the more sensitive or more specific definition. Our objective was to compare adjusting for the sensitive or specific definition… read more here.

Keywords: measurement binary; data simulation; binary covariates; claims data ... See more keywords

Identification of rheumatoid arthritis in German claims data using different algorithms: Validation by cross‐sectional patient‐reported survey data

Sign Up to like & get
recommendations!
Published in 2022 at "Pharmacoepidemiology and Drug Safety"

DOI: 10.1002/pds.5562

Abstract: To evaluate different algorithms for the identification of rheumatoid arthritis (RA) in claims data using patient‐reported diagnosis as reference. read more here.

Keywords: identification rheumatoid; patient reported; different algorithms; data using ... See more keywords

Using Pooled Electronic Health Records Data to Conduct Pharmacoepidemiology Safety Studies: Challenges and Lessons Learned.

Sign Up to like & get
recommendations!
Published in 2023 at "Pharmacoepidemiology and drug safety"

DOI: 10.1002/pds.5627

Abstract: PURPOSE We assessed the suitability of pooled electronic health record (EHR) data from Clinical Research Networks (CRNs) of the Patient-Centered Outcomes Research Network to conduct studies of the association between tumor necrosis factor inhibitors (TNFi)… read more here.

Keywords: conduct; ehr data; claims data; electronic health ... See more keywords

Validation of alopecia coding in US claims data among women of childbearing age

Sign Up to like & get
recommendations!
Published in 2024 at "Pharmacoepidemiology and Drug Safety"

DOI: 10.1002/pds.5782

Abstract: Accurately identifying alopecia in claims data is important to study this rare medication side effect. read more here.

Keywords: alopecia coding; among women; claims data; data among ... See more keywords

Validation of Chronic Inflammatory Demyelinating Polyradiculoneuropathy Coding in US Claims Data

Sign Up to like & get
recommendations!
Published in 2025 at "Pharmacoepidemiology and Drug Safety"

DOI: 10.1002/pds.70123

Abstract: Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is a rare autoimmune condition of the peripheral nervous system. The validity of the CIDP diagnosis code in claims data is unclear. read more here.

Keywords: validation chronic; claims data; inflammatory demyelinating; demyelinating polyradiculoneuropathy ... See more keywords

Quantification of Information Gained by Linking Claims Data to an Electronic Health Record Cohort of Patients With Metastatic Breast Cancer

Sign Up to like & get
recommendations!
Published in 2025 at "Pharmacoepidemiology and Drug Safety"

DOI: 10.1002/pds.70213

Abstract: Linking claims data to electronic health record (EHR) data can improve completeness, often at a cost of decreased sample size. Quantifying information gained and differences in patient characteristics between EHR and EHR‐claims linked cohorts may… read more here.

Keywords: data electronic; information gained; linking claims; electronic health ... See more keywords

Comparative assessment of manual chart review and ICD claims data in evaluating immunotherapy-related adverse events

Sign Up to like & get
recommendations!
Published in 2021 at "Cancer Immunology, Immunotherapy"

DOI: 10.1007/s00262-021-02880-0

Abstract: The aim of this retrospective study was to demonstrate that irAEs, specifically gastrointestinal and pulmonary, examined through International Classification of Disease (ICD) data leads to underrepresentation of true irAEs and overrepresentation of false irAEs, thereby… read more here.

Keywords: claims data; icd claims; icd; review ... See more keywords

Retrospective German claims data study on initial treatment of bladder carcinoma (BCa) by transurethral bladder resection (TURB): a comparative analysis of costs using standard white light- (WL-) vs. blue light- (BL-) TURB

Sign Up to like & get
recommendations!
Published in 2021 at "World Journal of Urology"

DOI: 10.1007/s00345-020-03587-0

Abstract: Photodynamic diagnosis using hexaminolevulinate (HAL)—guided BL-TURB may reduce the recurrence risk in non-muscle invasive BCa compared to standard WL-TURB due to more sensitive tumor detection. The impact of the initial use of WL- vs. BL-TURB… read more here.

Keywords: eur; analysis; bladder; claims data ... See more keywords

Different treatment forms of type II diabetes and the risk of dementia in German health claims data

Sign Up to like & get
recommendations!
Published in 2019 at "Acta Diabetologica"

DOI: 10.1007/s00592-019-01332-7

Abstract: AimsThe association between type II diabetes (T2D) and increased all-cause dementia risk is well established. However, to date, there is no definite proof that a specific therapy for diabetes can halt a progress of cognitive… read more here.

Keywords: risk; risk dementia; dementia; claims data ... See more keywords